TABLE 3.
Patient characteristics and clinicopathological factors by FBXW7 and MLST8 expression
| FBXW7 high | FBXW7 low | P value | MLST8 high | MLST8 low | P value | |
|---|---|---|---|---|---|---|
| No. of patients | 25 (31.6%) | 54 (68.4%) | 45 (60.0%) | 34 (40.0%) | ||
| Age | ||||||
| >60 | 11 (44.0%) | 31 (57.4%) | .267 | 27 (60.0%) | 15 (44.1%) | .161 |
| ≦60 | 14 (56.0%) | 23 (42.6%) | 18 (40.0%) | 19 (55.9%) | ||
| Gender | ||||||
| Male | 15 (60%) | 21 (38.9%) | .08 | 17 (37.8%) | 19 (55.9%) | .110 |
| Female | 10 (40%) | 33 (61.1%) | 28 (62.2%) | 15 (44.1%) | ||
| Size | ||||||
| >4 cm | 21 (84.0%) | 40 (74.1%) | .398 | 36 (80.0%) | 25 (73.5%) | .497 |
| ≦4 cm | 4 (16.0%) | 14 (25.9%) | 9 (20.0%) | 9 (26.5%) | ||
| Primary T stage | ||||||
| Low (pT1/pT2) | 21 (84.0%) | 43 (79.6%) | .449 | 32 (71.1%) | 32 (94.1%) | .009 |
| High (pT3/pT4) | 4 (16.0%) | 11 (20.4%) | 13 (28.9%) | 2 (5.9%) | ||
| TNM stage | ||||||
| Low (pT1/pT2) | 21 (84.0%) | 43 (79.6%) | .449 | 32 (71.1%) | 30 (88.2%) | .058 |
| High (pT3/pT4) | 4 (16.0%) | 11 (20.4%) | 13 (28.9%) | 4 (11.8%) | ||
| Fuhrman grade | ||||||
| Low (G1/G2) | 22 (88.0%) | 37 (68.5%) | .054 | 25 (55.6%) | 32 (94.1%) | .000 |
| High (G3/G4) | 3 (12.0%) | 17 (31.5%) | 20 (44.4%) | 2 (5.9%) | ||